Role of heparan sulfate in fibroblast growth factor signaling

Chemistry and Biology of Heparin and Heparan Sulfate

Volumn , Issue , 2005, Pages 399-434

  Harmer, Nicholas J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50549088569     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008044859-6/50015-0     Document Type: Chapter

References (106)

1. Ornitz DM FGFs, heparan sulphate and FGFRs: complex interactions essential for development. Bioessays 2000, 22:108-112.
2. Powers CJ, McLeskey SW, Wellstein A Fibroblast growth factors, their receptors and signaling. End-Rel Cancer 2000, 7:165-197.
3. Armelin HA Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc Nat Acad Sci USA 1973, 70:2702-2706.
4. Ornitz DM, Itoh N Fibroblast growth factors. Genome Biol 2001, 2. reviews3005.1-3005.12.
5. Harmer NJ, Chirgadze D, Kim KH, Pellegrini L, Blundell TL The structural biology of growth factor receptor activation. Biophys Chem 2003, 100:545-553.
6. Lin X Functions of heparan sulphate proteoglycans in cell signaling during development. Development 2004, 131:6009-6021.
7. Rapraeger AC, Krufka A, Olwin BB Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705-1708.
8. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 1992, 12:240-247.
9. Walker A, Turnbull JE, Gallagher JT Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem 1994, 269:931-935.
10. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell T Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 2000, 407:1029-1034.
11. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000, 6:743-750.
12. Sano H, Forough R, Maier JAM, Case JP, Jackson A, Engleka K, Macaig T, Wilder RL Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol 1990, 110:1417-1426.
13. Nedvetzki S, Golan I, Assayag N, Gonen E, Caspi D, Gladnikoff M, Yayon A, Naor D A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor. J Clin Invest 2003, 111:1211-1220.
14. Itoh N, Ornitz DM Evolution of the FGF and FGFR gene families. Trends Genet 2004, 20:563-569.
15. The ADHR Consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000, 26:345-348.
16. Gospodarowicz D Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 1974, 249:123-127.
17. Detillieux KA, Sheikh F, Kardami E, Cattini PA Biological activites of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003, 57:8-19.
18. Sutherland D, Samakovlis C, Krasnow MA Branchless encodes a Drosophila FGF homolog that controls tracheal cell migration and the pattern of branching. Cell 1996, 87:1091-1101.
19. Burdine RD, Chen EB, Kwok SF, Stern MJ egl-17 encodes an invertebrate fibroblast growth factor family member required specifically for sex myoblast migration in Caenorhabditis elegans. Proc Nat Acad Sci USA 1997, 94:2433-2437.
20. Harmer NJ, Chirgadze D, Pellegrini L, Fernandez-Recio J, Blundell TL The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry 2004, 43:629-640.
21. Innis CA, Shi J, Blundell TL Evolutionary trace analysis of TGF-beta and related growth factors: implications for site-directed mutagenesis. Prot Engin 2000, 13:839-847.
22. Miller DL, Ortega S, Bashayan O, Basch R, Basilico C Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol 2000, 20:2260-2268.
23. Folkman J, Shing J Angiogenesis. J Biol Chem 1992, 267:10931-10934.
24. Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M Requirement of FGF-4 for postimplantation mouse development. Science 1995, 267:246-249.
25. Han JK, Martin GR Embryonic expression of FGF-6 is restricted to the skeletal muscle lineage. Dev Biol 1993, 158:549-554.
26. Naski MC, Ornitz DM FGF signalling in skeletal development. Frontiers Biosci 1998, 3:d781-d794.
27. Meyers EN, Lewandoski M, Martin GR An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 1998, 18:136-141.
28. Min H, Danilenko DM, Scully S, Bolon B, Ring DB, Tarpley JE, DeRose M, Simonet WS FGF-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev 1998, 12:3156-3161.
29. Igarashi M, Finch PW, Aaronson SA Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J Biol Chem 1998, 273:13230-13235.
30. Olsen SK, Garbi M, Zampieri N, Eliseenkova AV, Ornitz DM, Glodfarb M, Mohammadi M FHFs share structural but not functional homology to FGFs. J Biol Chem 2003, 278:34226-34236.
31. Schoorlemmer J, Goldfarb M Fibroblast growth factor homologous factors are intracellular signaling proteins. Curr Biol 2001, 11:793-797.
32. Schlessinger J Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004, 306:1506-1507.
33. Sleeman M, Fraser J, McDonald M, Yuan S, White D, Grandison P, Kumble K, Watson JD, Murison JG Identification of a new fibroblast growth factor, FGFR5. Gene 2001, 271:171-182.
34. Burke DF, Wilkes D, Blundell TL, Malcolm S Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 1998, 23:59-62.
35. Xu J, Nakahara M, Crabb JW, Shi E, Matou Y, Fraser M, Kan M, Hou J, McKeehan WL Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. J Biol Chem 1992, 267:17792-17803.
36. Wang F, Kan M, Xu J, Yan G, McKeehan WL Ligand-specific structural domains in the fibroblast growth factor receptor. J Biol Chem 1995, 270:10222-10230.
37. Olsen SK, Ibrahimi OA, Raucci A, Zhang F, Eliseenkova AV, Yayon A, Basilico C, Linhardt RJ, Schlessinger J, Mohammadi M Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc Nat Acad Sci USA 2004, 101:935-1040.
38. Plotnikov AN, Schlessinger J, Hubbard SR, Mohammadi M Structural basis for FGF receptor dimerization and activation. Cell 1999, 98:641-650.
39. Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 2000, 101:413-424.
40. Stauber DJ, DiGabriele AD, Hendrickson WA Structural interactions of fibroblast growth factor receptor with its ligands. Proc Nat Acad Sci USA 2000, 97:49-54.
41. Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc Nat Acad Sci USA 2003, 100:2266-2271.
42. Kan M, Wang F, Xu J, Crabb JW, Hou J, McKeehan WL An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993, 259:1918-1921.
43. Vickers SM, Huang Z-Q, MacMillan-Crow L, Greendorfer JS, Thompson JA Ligand activation of alternatively spliced fibroblast growth factor receptor-1 modulates pancreatic adenocarcinoma cell malignancy. J Gastrointest Surg 2002, 6:546-553.
44. Ornitz DM, Xu J, Colvin JS, McEwan DG, MacArthur CA, Coulier F, Gao G, Goldfarb M Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996, 271:15292-15297.
45. Schlessinger J Cell signaling by receptor tyrosine kinases. Cell 2000, 103:211-225.
46. Li X, Brunton VG, Burgar HR, Wheldon LM, Heath JK FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activation. J Cell Sci 2004, 117:6007-6017.
47. Powell AK, Yates EA, Fernig DG, Turnbull JE Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology 2004, 14:17R-30R.
48. Thompson LD, Pantoliano MW, Springer BA Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry 1994, 33:3831-3840.
49. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC Heparin structure and interactions with basic fibroblast growth factor. Science 1996, 271:1116-1120.
50. DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, Hendrickson WA Structure of a heparin-linked biologically active dimmer of fibroblast growth factor. Nature 1998, 393:812-817.
51. Kreuger J, Salmivirta M, Sturiale L, Giménez-Gallego G, Lindahl U Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem 2001, 276:30744-30754.
52. Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 2004, 279:12346-12354.
53. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC Activating and inhibitory heparin sequences for FGF-2 (basic FGF). J Biol Chem 1993, 268:23906-23914. Distinct requirements for FGF-1, FGF-2, and FGF-4.
54. Bellosta P, Iwahori A, Plotnikov AN, Eliseenkova AV, Basilico C, Mohammadi M Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis. Mol Cell Biol 2001, 21:5946-5957.
55. Allen BL, Filla MS, Rapraeger AC Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol 2001, 155:845-857.
56. Ye S, Luo Y, Lu W, Jones RB, Linhardt RJ, Capila I, Toida T, Kan M, Pelletier H, McKeehan WL Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry 2001, 40:14429-14439.
57. Loo B-M, Salmivirta M Heparin/heparan sulfate domains in binding and signaling of fibroblast growth factor 8b. J Biol Chem 2002, 277:32616-32623.
58. Ford-Perriss M, Guimond SE, Greferath U, Kita M, Grobe K, Habuchi H, Kimata K, Esko JD, Murphy M, Turnbull JE Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling. Glycobiology 2002, 12:721-727.
59. Powell AK, Fernig DG, Turnbull JE Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. J Biol Chem 2002, 277:28554-28563.
60. Gao G, Goldfarb M Heparin can activate a receptor tyrosine kinase. EMBO J 1995, 14:2183-2190.
61. Loo B-M, Kreuger J, Jalkanen M, Lindahl U, Salmivirta M Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. J Biol Chem 2001, 276:16868-16876.
62. Pantoliano MW, Horlick RA, Springer BA, Van Dyk DE, Tobery T, Wetmore DR, Lear JD, Nahapetian AT, Bradley JD, Sisk WP Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994, 33:10229-10248.
63. MAPK phosphorylation and IkB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J Biol Chem 2000, 275:33905-33910.
64. Deepa SS, Umehara Y, Higashiyama S, Itoh N, Sugahara K Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. J Biol Chem 2002, 277:43707-43716.
65. Villena J, Brandan E Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration. J Cell Physiol 2004, 198:169-178.
66. Nandini CD, Mikami T, Ohta M, Itoh N, Akiyama-Nambu F, Sugahara K Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish. Neuritogenic and binding activities for growth factors and neurotrophic factors. J Biol Chem 2004, 279:50799-50809.
67. Delehedde M, Lyon M, Gallagher J, Rudland PS, Fernig DG Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. Biochem J 2002, 366:235-244.
68. Maccarana M, Casu B, Lindahl U Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 1993, 268:23898-23905.
69. Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn CM, Waksman G FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 1995, 268:432-436.
70. Ostrovsky O, Berman B, Gallagher J, Mulloy B, Fernig DG, Delehedde M, Ron D Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem 2002, 277:2444-2453.
71. Berry D, Shriver Z, Venkataraman G, Sasisekharan R Quantitative assessment of FGF regulation by cell surface heparan sulfates. Biochem Biophys Res Commun 2004, 314:994-1000.
72. Wang S, Ai X, Freeman SD, Pownall ME, Lu Q, Kessler DS, Emerson CP QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm indction and angiogenesis. Proc Nat Acad Sci USA 2004, 101:4833-4838.
73. Merry CL, Bullock SL, Swan DC, Backen AC, Lyon M, Beddington RS, Wilson VA, Gallagher JT The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J Biol Chem 2001, 276:35429-35434.
74. Toyoda H, Kinoshita-Toyoda A, Fox B, Selleck SB Structural analysis of glycosaminoglycans in animals bearing mutations in sugarless, sulfateless, and tout-velu. Drosophila homologues of vertebrate genes encoding glycosaminoglycan biosynthetic enzymes. J Biol Chem 2000, 275:21856-21861.
75. Luders F, Segawa H, Stein D, Selva EM, Perrimon N, Turco SJ, Hacker U Slalom encodes an adenosine 3'-phosphate 5'-phosphosulfate transporter essential for development in Drosophila. EMBO J 2003, 22:3635-3644.
76. Allen BL, Rapraeger AC Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor mediated assembly. J Cell Biol 2003, 163:637-648.
77. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994, 79:1015-1024.
78. Anderson J, Burns HD, Enriquez-Harris P, Wilkie AOM, Heath JK Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet 1998, 7:1475-1483.
79. Ibrahimi OA, Zhang F, Eliseenikova AV, Linhardt RJ, Mohammadi M Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet 2004, 13:69-78.
80. Ibrahimi OA, Zhang F, Hrstka SC, Mohammadi M, Linhardt RJ Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 2004, 43:4724-4730.
81. Harmer NJ, Ilag LL, Pellegrini L, Mulloy B, Robinson CV, Blundell TL Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex. J Mol Biol 2004, 339:821-834.
82. Anderson AC The process of structure-based drug design. Chem Biol 2003, 10:787-797.
83. Mulloy B, Forster MJ Conformation and dynamics of heparin and heparan sulfate. Glycobiology 2000, 10:1147-1156.
84. Mulloy B, Forster MJ, Jones C, Davies DB NMR and molecular-modelling studies of the solution conformation of heparin. Biochem J 1993, 293:849-858.
85. Mulloy B, Forster MJ, Jones C, Drake AF, Johnson EA, Davies DB The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study. Carbohydr Res 1994, 255:1-26.
86. Mikhailov D, Mayo KH, Vlahov IR, Toida T, Pervin A, Linhardt RJ NMR solution conformation of heparin-derived tetrasaccharide. Biochem J 1996, 318:93-102.
87. Mikhailov D, Linhardt RJ, Mayo KH NMR solution conformation of heparin-derived hexasaccharide. Biochem J 1997, 328:51-61.
88. Stevens EJ, Sathyanarayama BK Potential energy surfaces of cellobiose and maltose in aqueous solution: a new treatment of disaccharide optical rotation. J Am Chem Soc 1989, 111:4149-4154.
89. Dowd MK, French AD, Reilly PJ Conformational analysis of the anomeric forms of sophorose, laminarabiose and cellobiose using MM3. Carbohydr Res 1992, 233:15-34.
90. Dowd MK, Zeng J, French AD, Reilly PJ Conformational analysis of the anomeric forms of kojibiose, nigerose and maltose using MM3. Carbohydr Res 1992, 230:223-244.
91. Eriksson AE, Cousens LS, Weaver LH, Matthews BW Three-dimensional structure of human basic fibroblast growth factor. Proc Nat Acad Sci USA 1991, 88:3441-3445.
92. Zhu X, Komiya H, Chirino A, Faham S, Fox GM, Arakawa T, Hsu BT, Rees DC Three-dimensional structures of acidic and basic fibroblast growth factors. Science 1991, 251:90-93.
93. Zhang JD, Cousens LS, Barr PJ, Sprang SR Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc Nat Acad Sci USA 1991, 88:3446-3450.
94. Hecht HJ, Adar R, Hofmann B, Bogin O, Weich H, Yayon A Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces. Acta Crystallogr D: Biol Crystallogr 2001, 57:378-384.
95. Plotnikov AN, Eliseenkova AV, Ibrahimi OA, Shriver Z, Sasisekharan R, Lemmon MA, Mohammadi M Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. J Biol Chem 2001, 276:4322-4329.
96. DeLano WL The Pymol Molecular Graphics System 2002, DeLano Scientific, San Carlos, CA.
97. Sali A, Blundell TL Definition of general topological equivalence in protein structures: a procedure involving comparison of properties and relationships through simulated annealing and dynamic programming. J Mol Biol 1990, 212:403-428.
98. Shi J, Blundell TL, Mizuguchi K FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol 2001, 310:243-257.
99. Ogura K, Nagata K, Hatanaka H, Habuchi H, Kimata K, Tate S-I, Ravera MW, Jaye M, Schlessinger J, Inagaki K Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide. J Biomol NMR 1999, 13:11-24.
100. Moy FJ, Seddon AP, Campell EB, Bohlen P, Powers R 1H, 15N, 13C and 13CO assignments and secondary structure determination of basic fibroblast growth factor using 3D heteronuclear NMR spectroscopy. J Biomol NMR 1995, 6:245-254.
101. Faham S, Linhardt RJ, Rees DC Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr Opin Struct Biol 1998, 8:578-586.
102. Pellegrini L Role of heparan sulphate in fibroblast growth factor signalling: a structural view. Curr Opin Struct Biol 2001, 11:629-634.
103. Ibrahimi OA, Zhang F, Eliseenikova AV, Itoh N, Linhardt RJ, Mohammadi M Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet 2004, 13:2313-2324.
104. Zhang Z, Coomans C, David G Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model. J Biol Chem 2001, 276:41921-41929.
105. Wu ZL, Zhang L, Yabe T, Kuberan B, Beeler DL, Love A, Rosenberg RD The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem 2003, 278:17121-17129.
106. Ibrahimi OA, Yeh BK, Eliseenikova AV, Zhang F, Olsen SK, Igarashi M, Aaronson SA, Linhardt RJ, Mohammadi M Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Mol Cell Biol 2005, 25:671-684.